<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8485281</identifier>
<setSpec>0212-7199</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">The response to the therapy with captopril administered in one daily dose (between 25 and 100 mg) to a group of 468 old patients with arterial hypertension has been studied. In 87% of the cases, normalization of the arterial pressure was achieved at six months (values lower than 160/95 mmHg). The therapy resulted in a progressive reduction during the follow-up period, with a significant initial reduction (p &lt; 0.001). Just 7.5% of the patients needed the administration of diuretics in addition to the therapy. Just nine patients had to discontinue the follow-up due to side effects (dry cough in 4; gastrointestinal disorders in 4; postural hypertension in 1 case). We conclude that captopril administered in one daily dose is a safe and effective therapy for the treatment of mild to moderate arterial hypertension among the elderly.</dc:description>
<dc:type>Clinical Trial</dc:type>
<dc:language>es</dc:language>
<dc:date>1993 Mar </dc:date>
<dc:title xml:lang="es">Captopril en dosis única diaria en la hipertensión arterial del anciano. Estudio cooperativo de Badajoz. Grupo Cooperativo de Badajoz.</dc:title>
<dc:title xml:lang="en">[Captopril in a single daily dose in arterial hypertension in the elderly. The Badajoz cooperative study. The Badajoz Cooperative Group].</dc:title>
<dc:publisher>Anales de medicina interna (Madrid, Spain : 1984)</dc:publisher>
</metadata>
</record>
</pubmed-document>
